Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01607619 · ClinicalTrials.gov registry record · NA
Effect of Anatabine on Elevated Blood Levels of C-reactive Protein
A NA study of Inflammation, sponsored by Roskamp Institute.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
- 3
- Study locations
NCT01607619 is a NA study of Inflammation that has completed, run by Roskamp Institute. The registered enrollment target is 117 participants, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (59% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT01607619, a NA study of Inflammation, has completed, sponsored by Roskamp Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators are studying a dietary supplement called anatabine in a lozenge form named RCP006. The main purpose of this study is to evaluate the effects of this dietary supplement on normal human inflammatory function. The investigators will see this effect in volunteers who have markers of higher levels of inflammation to begin with. The investigators anticipate that anatabine will reduce markers of inflammation. Therefore the investigators are looking for volunteers with high blood levels of C-reactive Protein (CRP) and will monitor the blood CRP levels at several time points throughout the study.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Anatabine
Study Locations (3)
Michigan
- McLaren Community Medical Center - Flint
- Medical Practice - Shelby
Florida
- The Roskamp Institute, Inc. - Sarasota
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01607619
The ClinicalTrials.gov registry entry for NCT01607619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 132 other Inflammation trials with a reported enrollment target (59% lower). The listed sponsor is Roskamp Institute, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Anatabine is the first listed.
NCT01607619 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Florida.
Frequently Asked Questions
What is clinical trial NCT01607619 about?
NCT01607619 is a clinical study titled "Effect of Anatabine on Elevated Blood Levels of C-reactive Protein". The investigators are studying a dietary supplement called anatabine in a lozenge form named RCP006. The main purpose of this study is to evaluate the effects of this dietary supplement on normal human inflammatory function. The investigators will see this effect in volunteers who have markers of hi...
What is the current status of trial NCT01607619?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2011-05. Estimated completion is 2013-01.
What conditions does trial NCT01607619 study?
This clinical trial studies the following conditions: Inflammation.
What interventions are being tested in trial NCT01607619?
The interventions under investigation include: Anatabine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01607619?
This trial is sponsored by Roskamp Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01607619 being conducted?
This trial has 3 study locations across Florida, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.